InvestorsHub Logo
Followers 10
Posts 212
Boards Moderated 0
Alias Born 04/26/2017

Re: greens12 post# 373

Saturday, 06/17/2017 6:40:51 PM

Saturday, June 17, 2017 6:40:51 PM

Post# of 1954
Study says dosed once daily. It takes a good amt of time for the drug to clear- always nice to have a drug that can be dosed once a day. 12 weeks I think of patient dosing. I don't think the recent updates on data collection on the trials website means we were delayed further. June (or even July) data is spot on with the last earnings call. From what I can tell, the June date we are talking about is when the last patient gets dosed. Trial summary says they will monitor people for 3-7 weeks post that. So for example primary completion date late June/early July + 7 weeks (followup monitoring) = late august/early sept. They said on the call I think that it will take them 3-4 weeks to do final data cleanup (reasonable). That puts results, if everything takes the most time and data analysis doesn't become a mess, puts us in sept/oct range. The closer this date gets to the lipid trail release at end of year, the more potential upside, imo.
I don't know anything about the sites or what has chanted, if anything. Trial is nearing completion, maybe they never used some of those trial sites and its record keeping, maybe they are closing it down, maybe there was other stuff going on with trial sites to explain our slower enrollment, nobody knows until the conference call after data, and by then it probably won't have the same relevance as now.
Still have a good feeling about this one. Have a nice weekend all
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VKTX News